Avistone
Beijing Avistone Biotechnology Co., Ltd. is a commercial-stage innovative biopharmaceutical company headquartered in Beijing, China, focused on the research, development, and commercialization of first-in-class and best-in-class oncology therapies. Founded in 2012 (originally Beijing Pearl Biotechnology) and renamed Avistone in 2018, the company has two approved cancer drugs on the market: Vebreltinib (万比锐®), a MET inhibitor approved for non-small cell lung cancer and glioma indications and included in China's National Reimbursement Drug List, and Andamertinib (安比锐®), an EGFR exon 20 insertion inhibitor approved in 2026 for advanced NSCLC. Avistone maintains a pipeline of additional candidates (ANS01 through ANS09) across solid-tumor indications and is backed by IDG Capital. The company publishes no public developer API or programmatic surface; this profile captures its corporate and investor identity.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Avistone is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Avistone scores 8.8/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
Resources
Every other property we hold for Avistone — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Commercial 1
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Avistone is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/avistone · machine-readable index on apis.io